Literature DB >> 33215435

Diagnostic accuracy of fasting plasma glucose as a screening test for gestational diabetes mellitus: a systematic review and meta-analysis.

M Li1, J-R Lan, J-L Liang, X-L Xiong.   

Abstract

OBJECTIVE: Fasting plasma glucose (FPG) is suggested as a potential screening test for further confirmatory testing by oral glucose tolerance test (OGTT) for diagnosing gestational diabetes mellitus (GDM). The diagnostic accuracy of FPG has been investigated in several studies with varying results. This meta-analysis is done to evaluate the diagnostic accuracy of FPG for the screening of GDM.
MATERIALS AND METHODS: We conducted a systematic search for all studies reporting the diagnostic accuracy of FPG with OGTT as the reference standard in the databases of Medline, Scopus, Cochrane and Embase from inception till January 2020. Quality assessment of diagnostic accuracy studies-2 tool was used to assess the quality of trials.
RESULTS: 29 studies with 74,481 patients were included. Eleven studies used the cut-off values of 92mg/dl for FPG to diagnose GDM, whereas 10 studies used the value of 92 mg/dl. The pooled sensitivity and specificity of FPG for cut-off ≥92 mg/dl was 68.6% (95% CI: 51.8%-81.9%), and 93.2% (95% CI: 80.5%-97.8%) respectively. The AUC was 0.88 (95% CI: 0.79-0.94). The pooled sensitivity and specificity of FPG for cut-off ≥90 mg/dl was 58.5% (95% CI: 41.1%-73.9%), and 89.2% (95% CI: 78.5%-94.9%) respectively. The AUC was 0.83 (95% CI: 0.75-0.91). The overall quality of studies was moderate.
CONCLUSIONS: To summarize, our study found that FPG may have a role in the screening of GDM among pregnant women with satisfactory sensitivity and specificity at a cut-off of 92 mg/dl. Further studies exploring its accuracy in different ethnic populations in reference to a standard OGTT are required to strengthen the evidence.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33215435     DOI: 10.26355/eurrev_202011_23605

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Association between the cut-off value of the first trimester fasting plasma glucose level and gestational diabetes mellitus: a retrospective study from southern China.

Authors:  Jia-Ning Tong; Yi-Xuan Chen; Xiao-Nian Guan; Kan Liu; Ai-Qi Yin; Hua-Fan Zhang; Lin-Lin Wu; Jian-Min Niu
Journal:  BMC Pregnancy Childbirth       Date:  2022-07-04       Impact factor: 3.105

2.  Fasting plasma glucose level to guide the need for an OGTT to screen for gestational diabetes mellitus.

Authors:  Kaat Beunen; Astrid Neys; Paul Van Crombrugge; Carolien Moyson; Johan Verhaeghe; Sofie Vandeginste; Hilde Verlaenen; Chris Vercammen; Toon Maes; Els Dufraimont; Nele Roggen; Christophe De Block; Yves Jacquemyn; Farah Mekahli; Katrien De Clippel; Annick Van Den Bruel; Anne Loccufier; Annouschka Laenen; Roland Devlieger; Chantal Mathieu; Katrien Benhalima
Journal:  Acta Diabetol       Date:  2021-11-01       Impact factor: 4.280

3.  Performance of guidelines for the screening and diagnosis of gestational diabetes mellitus during the COVID-19 pandemic: A scoping review of the guidelines and diagnostic studies evaluating the recommended testing strategies.

Authors:  Aisling M Curtis; Andrew J Farmer; Nia W Roberts; Laura C Armitage
Journal:  Diabet Epidemiol Manag       Date:  2021-11-06

4.  Fasting plasma glucose in the first trimester is related to gestational diabetes mellitus and adverse pregnancy outcomes.

Authors:  Jia-Ning Tong; Lin-Lin Wu; Yi-Xuan Chen; Xiao-Nian Guan; Fu-Ying Tian; Hua-Fan Zhang; Kan Liu; Ai-Qi Yin; Xiao-Xia Wu; Jian-Min Niu Prof
Journal:  Endocrine       Date:  2021-08-03       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.